🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

55+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 55 recruiting trials for “Alopecia

Phase 1, PHASE2RecruitingNCT06239324

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

👨‍⚕️ Soheir AbdelHamid Ali, Assist. Prof., Department of dermatology , Venerolgy and Andrology Faculty of Medicine Qena university📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06283316

Systemic Treatments for Alopecia Areata Registry

🏥 Erasmus Medical Center📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT05460611

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

👨‍⚕️ Kseniya Kobets, MD, Albert Einstein College of Medicine Montefiore Medical Center📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06955702

Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients

👨‍⚕️ Marta González Fernández-Conde, Universidad Salamanca📍 2 sites📅 Started Nov 2023View details ↗
Phase 3RecruitingNCT06012240

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

👨‍⚕️ ABBVIE INC., AbbVie📍 267 sites📅 Started Oct 2023View details ↗
NARecruitingNCT06011525

Prevention of Alopecia in Patients With Localised Breast Cancer

🏥 Centre Francois Baclesse📍 3 sites📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT05551793

Regeneron AA Multicenter (Dupilumab)

👨‍⚕️ Emma Guttman-Yassky, MD, PhD, Icahn School of Medicine at Mount Sinai📍 3 sites📅 Started Apr 2023View details ↗
EARLY_Phase 1RecruitingNCT05417308

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

👨‍⚕️ Brittany L Dulmage, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05723198

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 127 sites📅 Started Feb 2023View details ↗
RecruitingNCT05745389

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

🏥 CorEvitas📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05213936

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

👨‍⚕️ Beth McLellan, MD, Montefiore Medical Center📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05612100

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

👨‍⚕️ Elizabeth Cathcart-Rake, M.D., Mayo Clinic in Rochester📍 23 sites📅 Started Jul 2022View details ↗
NARecruitingNCT05365360

Sham LaserCap vs. LaserCap SD vs. LaserCap HD+

🏥 University of Arizona📍 1 site📅 Started Jun 2022View details ↗
NARecruitingNCT05177289

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

👨‍⚕️ Jeroen Mebis, Prof. Dr., Jessa Hospital📍 1 site📅 Started Feb 2022View details ↗
NARecruitingNCT05938569

Computer-Assisted Hair Restoration Study Using ARTAS System

🏥 Venus Concept📍 2 sites📅 Started Nov 2016View details ↗
← PreviousPage 3 of 3

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →